WallStSmart

The Glimpse Group, Inc. (GGRP)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 3298% more annual revenue ($258.90M vs $7.62M). ZEPP leads profitability with a -15.5% profit margin vs -50.2%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

GGRP

Avoid

28

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GGRP.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GGRP1 strengths · Avg: 10.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

GGRP4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$10.83M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-23.1%2/10

ROE of -23.1% — below average capital efficiency

Revenue GrowthGrowth
-59.0%2/10

Revenue declined 59.0%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : GGRP

The strongest argument for GGRP centers on Price/Book.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : GGRP

The primary concerns for GGRP are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

GGRP profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 28/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Glimpse Group, Inc.

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

The Glimpse Group, Inc. (GGRP) is a prominent player in the immersive technology sector, specializing in augmented reality (AR) and virtual reality (VR) solutions tailored for various industries, such as education, healthcare, and corporate training. With a strategic focus on innovation, the company manages a diverse portfolio of subsidiaries that enhance its capacity to deliver cutting-edge applications. Glimpse's proactive approach includes product development, strategic partnerships, and targeted acquisitions, ensuring it is well-equipped to seize the burgeoning market demand for immersive experiences. Supported by a skilled team and a dedication to the advancement of AR/VR technologies, Glimpse is poised for sustained growth and seeks to maximize shareholder value in an increasingly digital world.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?